Erin Fry has notable professional experience on healthcare, budget & appropriations, defense, medical research & clinical labs, and copyright, patent & trademark issues. Erin previously worked at Fabiani & Company with no active client. Erin has represented 16 total clients.

Practice Areas

Areas of Experience

DOCBOX INC - Health Care Technology Development
Duration : 1.7 years (2008 - 2009) inactive
Revenue : $0.00 (monthly) - $60,000.00 (total)
- Health IT, Appropriations, Defense Authorization

Cempra Pharmaceuticals Inc. - Antibiotics
Duration : 3.8 years (2006 - 2010) inactive
Revenue : $0.00 (monthly) - $585,000.00 (total)
- Incentives for antibiotic innovation

MEDRAD, INC
Duration : 2.2 years (2008 - 2010) inactive
Revenue : $13,333.00 (monthly) - $560,000.00 (total)
- HR 6331 Medicare Bill- Issues pertaining to physician reimbursement for medical imaging procedures

Ocera Therapeutics Inc. - Biopharmaceutical product development & research
Duration : 1.5 years (2008 - 2010) inactive
Revenue : $20,000.00 (monthly) - $560,000.00 (total)
- Funding for biopharmaceutical product development to address nuclear warfare threats.

NANOTHERAPEUTICS INC - Biopharmaceutical R&D and manufacturing
Duration : 1.5 years (2008 - 2010) inactive
Revenue : $16,667.00 (monthly) - $420,000.00 (total)
- FY 2010 Department of Defense Appropriations Act. Funding for army medical research.

CLINICAL DATA INC - Company dealing with laboratory testing, genetics and genomics
Duration : 2.0 years (2008 - 2009) inactive
Revenue : $16,667.00 (monthly) - $395,000.00 (total)
- Exclusive licensure of genetic associations

BRAINCELLS INC - Pharmaceutical Development
Duration : 1.7 years (2008 - 2009) inactive
Revenue : $10,000.00 (monthly) - $320,000.00 (total)
- CDMRP - BAA 2007 Defense Appropriations RDT&E

TRF Coalition - Coalition for the abuse deterrent formulations of pharmaceutical products
Duration : 0.7 years (2008 - 2009) inactive
Revenue : $13,333.00 (monthly) - $190,000.00 (total)
- Abuse deterrent formulations of pharmaceutical products

PointCare Technologies Inc. - Remote monitoring of HIV and related diseases
Duration : 1.0 years (2008 - 2009) inactive
Revenue : $13,333.00 (monthly) - $150,000.00 (total)
- U.S. President's Emergency Plan for AIDs Relief, Appropriations

SPALTUDAQ CORPORATION - Biotech: Monoclonal Antibody Discovery Platform
Duration : 1.7 years (2008 - 2009) inactive
Revenue : $0.00 (monthly) - $145,000.00 (total)
- DTRA BAA 2007 RDT&E Defense Appropriations 2009 Budget

Crim Fitness Foundation, Inc. - Health promotion, fitness, nutrition and obesity prevention
Duration : 1.0 years (2009 - 2009) inactive
Revenue : $0.00 (monthly) - $130,000.00 (total)
- Appropriation, physical activity promotion

PLANET BIOTECHNOLOGY INC - Pharmaceuticals
Duration : 0.5 years (2008 - 2008) inactive
Revenue : $20,000.00 (monthly) - $120,000.00 (total)
- Department of Defense Appropriations Act of 2009, funding for biodefense product research

AKESIS PHARMACEUTICALS INC - Pharmaceutical Development
Duration : 0.7 years (2008 - 2008) inactive
Revenue : $0.00 (monthly) - $110,000.00 (total)
- Defense appropriations RDT&E

Lundbeck Research USA, Inc. - Neurological Pharmaceuticals
Duration : 0.5 years (2009 - 2009) inactive
Revenue : $0.00 (monthly) - $100,000.00 (total)
- Health Reform
DOCBOX INC - Health Care Technology Development
Duration : 1.7 years (2008 - 2009) inactive
Revenue : $0.00 (monthly) - $60,000.00 (total)
- Pathogen Detection FY 2009 DOD Appropriations & Authorization Legislation

Ocera Therapeutics Inc. - Biopharmaceutical product development & research
Duration : 1.5 years (2008 - 2010) inactive
Revenue : $20,000.00 (monthly) - $560,000.00 (total)
- Funding for biopharmaceutical product development with the Department of Defense to treat long term health impact of chronic substance abuse.

NANOTHERAPEUTICS INC - Biopharmaceutical R&D and manufacturing
Duration : 1.5 years (2008 - 2010) inactive
Revenue : $16,667.00 (monthly) - $420,000.00 (total)
- FY 2010 Department of Defense Appropriations Act. Funding for army medical research.

BRAINCELLS INC - Pharmaceutical Development
Duration : 1.7 years (2008 - 2009) inactive
Revenue : $10,000.00 (monthly) - $320,000.00 (total)
- CDMRP - BAA 2007 Defense Appropriations RDT&E

SPALTUDAQ CORPORATION - Biotech: Monoclonal Antibody Discovery Platform
Duration : 1.7 years (2008 - 2009) inactive
Revenue : $0.00 (monthly) - $145,000.00 (total)
- HR 3326; FY10 Defense Appropriations Act; Army Research and Development for HIV Vaccine Research

PLANET BIOTECHNOLOGY INC - Pharmaceuticals
Duration : 0.5 years (2008 - 2008) inactive
Revenue : $20,000.00 (monthly) - $120,000.00 (total)
- Department of Defense Appropriations Act of 2009, provisions relating to DARPA medical research (RDT&E)
Cempra Pharmaceuticals Inc. - Antibiotics
Duration : 3.8 years (2006 - 2010) inactive
Revenue : $0.00 (monthly) - $585,000.00 (total)
- Funding for drug development

MEDRAD, INC
Duration : 2.2 years (2008 - 2010) inactive
Revenue : $13,333.00 (monthly) - $560,000.00 (total)
- Department of Energy and Water and Related Agencies Appropriations Act of 2010, for medical imaging research

Ocera Therapeutics Inc. - Biopharmaceutical product development & research
Duration : 1.5 years (2008 - 2010) inactive
Revenue : $20,000.00 (monthly) - $560,000.00 (total)
- Fiscal Year 2010 Defense Appropriations Act. Funding for biopharmaceutical product trials for treatment to address long term health impact of substance abuse in military populations.

NANOTHERAPEUTICS INC - Biopharmaceutical R&D and manufacturing
Duration : 1.5 years (2008 - 2010) inactive
Revenue : $16,667.00 (monthly) - $420,000.00 (total)
- Department of Defense Appropriations Act of 2010, provisions relating to Army medical research

PLANET BIOTECHNOLOGY INC - Pharmaceuticals
Duration : 0.5 years (2008 - 2008) inactive
Revenue : $20,000.00 (monthly) - $120,000.00 (total)
- Department of Defense Appropriations Act of 2009, provisions relating to DARPA medical research (RDT&E)
Cempra Pharmaceuticals Inc. - Antibiotics
Duration : 3.8 years (2006 - 2010) inactive
Revenue : $0.00 (monthly) - $585,000.00 (total)
- Funding for drug development; sample procurement

Trius Therapeutics - Medical technology company
Duration : 2.0 years (2008 - 2010) inactive
Revenue : $6,667.00 (monthly) - $400,000.00 (total)
- Antibiotics, BioDefense

CLINICAL DATA INC - Company dealing with laboratory testing, genetics and genomics
Duration : 2.0 years (2008 - 2009) inactive
Revenue : $16,667.00 (monthly) - $395,000.00 (total)
- S.976 Genomics and Personalized Medicine Act of 2007, Realizing the potential of personalized medicine; and Exclusive licensure of genetic associations

BRAINCELLS INC - Pharmaceutical Development
Duration : 1.7 years (2008 - 2009) inactive
Revenue : $10,000.00 (monthly) - $320,000.00 (total)
- CDMRP - BAA 2007 Defense Appropriations RDT&E

SPALTUDAQ CORPORATION - Biotech: Monoclonal Antibody Discovery Platform
Duration : 1.7 years (2008 - 2009) inactive
Revenue : $0.00 (monthly) - $145,000.00 (total)
- DTRA BAA 2007 RDT&E Defense Appropriations 2009 Budget
MEDRAD, INC
Duration : 2.2 years (2008 - 2010) inactive
Revenue : $13,333.00 (monthly) - $560,000.00 (total)
- S 515 Patent Reform Act, provisions relating to apportionment of damages
Wounded Warrior Project
Duration : 0.5 years (2009 - 2009) inactive
Revenue : $10,000.00 (monthly) - $60,000.00 (total)
- Veterans issuies, military and veterans families

NANOTHERAPEUTICS INC - Biopharmaceutical R&D and manufacturing
Duration : 1.5 years (2008 - 2010) inactive
Revenue : $16,667.00 (monthly) - $420,000.00 (total)
- Research partnerships on treatments to address opiate addiction
MEDRAD, INC
Duration : 2.2 years (2008 - 2010) inactive
Revenue : $13,333.00 (monthly) - $560,000.00 (total)
- H.R.1409, Employee Free Choice Act of 2009; S. 560, Employee Free Choice Act of 2009

SPALTUDAQ CORPORATION - Biotech: Monoclonal Antibody Discovery Platform
Duration : 1.7 years (2008 - 2009) inactive
Revenue : $0.00 (monthly) - $145,000.00 (total)
- DTRA BAA 2007 RDT&E Defense Appropriations 2009 Budget
MEDRAD, INC
Duration : 2.2 years (2008 - 2010) inactive
Revenue : $13,333.00 (monthly) - $560,000.00 (total)
- Addressing trade barriers for medical devices in Australia
SPALTUDAQ CORPORATION - Biotech: Monoclonal Antibody Discovery Platform
Duration : 1.7 years (2008 - 2009) inactive
Revenue : $0.00 (monthly) - $145,000.00 (total)
- DTRA BAA 2007 RDT&E Defense Appropriations 2009 Budget
TRF Coalition - Coalition for the abuse deterrent formulations of pharmaceutical products
Duration : 0.7 years (2008 - 2009) inactive
Revenue : $13,333.00 (monthly) - $190,000.00 (total)
- Abuse deterrent formulations of pharmaceutical products
Cempra Pharmaceuticals Inc. - Antibiotics
Duration : 3.8 years (2006 - 2010) inactive
Revenue : $0.00 (monthly) - $585,000.00 (total)
- Funding; Sample Procurement
Crim Fitness Foundation, Inc. - Health promotion, fitness, nutrition and obesity prevention
Duration : 1.0 years (2009 - 2009) inactive
Revenue : $0.00 (monthly) - $130,000.00 (total)
- HR 3288; FY10 Transportation/HUD Appropriations Act; Economic/Urban Development for blighted property in Flint, Michigan

Top Expertise

  • HEALTHCARE
  • BUDGET & APPROPRIATIONS
  • DEFENSE
  • MEDICAL RESEARCH & CLINICAL LABS
  • COPYRIGHT
  • PATENT & TRADEMARK

Clients

Current

Past

  • AKESIS PHARMACEUTICALS INC
  • BRAINCELLS INC
  • CLINICAL DATA INC
  • Cempra Pharmaceuticals Inc.
  • Crim Fitness Foundation, Inc.
  • DOCBOX INC
  • Lundbeck Research USA, Inc.
  • MEDRAD, INC
  • NANOTHERAPEUTICS INC
  • Ocera Therapeutics Inc.
  • PLANET BIOTECHNOLOGY INC
  • PointCare Technologies Inc.
  • SPALTUDAQ CORPORATION
  • TRF Coalition
  • Trius Therapeutics
  • Wounded Warrior Project